Ketamine Patients and GLP-1 Patients Are Often the Same People
47 percent of peptide clinics now offer a GLP-1. Depression, drinking and metabolic disease cluster in the same patients.
Read MoreB2B resources and operational guidance for ketamine and psychedelic clinic owners.
47 percent of peptide clinics now offer a GLP-1. Depression, drinking and metabolic disease cluster in the same patients.
Read More
A Chicago company is betting that better mental health treatment starts with a better assessment. MindMetrix has built a comprehensive
Read More
Lilly paid up to $3.8 billion for a compound whose selling point is a two hour clinic visit. Session length,
Read More
Eli Lilly, the world’s largest pharmaceutical company, confirmed Thursday morning that it will acquire AtaiBeckley in a deal worth up
Read More
Johnson & Johnson, Mindbloom and BetterU are all bidding on generic psychedelic search terms. Here is what that does to
Read More
Two 2024 randomized trials cut cluster headache attacks with pulse dose psilocybin. Where ketamine sits, why these patients overlap with
Read More
A recent JD Supra analysis looks at what Todd Blanche’s nomination for attorney general could mean for marijuana and psychedelic
Read More
SAMHSA told states to build the budget, licensing, and oversight machinery for psychedelic therapy before the FDA approves anything. Ketamine
Read More
Ketamine can reduce pain while producing an altered sense of self. A new study suggests they may travel along separate
Read More
A Center for Health Care Strategies report examines how psychedelic-assisted therapy could reach Medicaid. Some states already cover off-label IV
Read More